SHINE Technologies is partnering with Primo Biotechnology, a developer of high-precision radiopharmaceuticals, the company announced today. According to a release, the agreement grants Primo exclusive distribution rights for SHINE’s Ilumira…
NorthStar Medical Radioisotopes and YAP Therapeutics are entering a collaboration agreement to develop and produce radiopharmaceuticals aimed at treating cancer and other chronic diseases, NorthStar announced today. According to a…
Axio BioPharma, an antibody manufacturing and process development company, announced recently that it is partnering with eMBR Genomics, a biotech company focused on early multi-cancer detection, to manufacture and distribute…
Imbed Biosciences named Terry Bromley its new Chief Executive Officer, the company announced recently. According to a release, Bromley has more than 30 years of experience in the medical device,…
NorthStar Medical Radioisotopes and Ariceum Therapeutics have signed a supply agreement for therapeutic medical radioisotope actinium-225 (Ac-225), the company announced recently. According to a release, NorthStar will supply non-carrier added…
AbbVie, a biotech company that develops and commercializes medicines, announced today that it will acquire Nimble Therapeutics. According to a release, the proposed acquisition adds Nimble’s lead asset, which is…
Forward BIOLABS announced recently the 15 biohealth startups that will receive a membership. According to a release, the Forward Membership program, which is supported by the Wisconsin Economic Development Corporation…
SpayVac for Wildlife, Inc., in partnership with BioVaxys Technology Corp., has expanded production capacity at its Madison facility to support global demand for its fertility-control vaccines for animals, the company…
Cellectar Biosciences and NorthStar Medical Radioisotopes have signed a strategic supply agreement for the procurement of NorthStar’s non-carrier added (n.c.a.) Ac-225, the company announced today. “We plan to advance CLR…
Exact Sciences will be sharing results for its multi-cancer early detection (MCED) test at the American Association for Cancer Research (AACR) Special Conference taking place Nov. 13-16 in San Diego,…
